IDLYBRA Trademark

Trademark Overview


On Tuesday, October 31, 2023, a trademark application was filed for IDLYBRA with the United States Patent and Trademark Office. The USPTO has given the IDLYBRA trademark a serial number of 98248054. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, October 28, 2024. This trademark is owned by Merck Sharp & Dohme LLC. The IDLYBRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders
idlybra

General Information


Serial Number98248054
Word MarkIDLYBRA
Filing DateTuesday, October 31, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events


Event DateEvent Description
Friday, November 3, 2023NEW APPLICATION ENTERED
Friday, February 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 1, 2024ASSIGNED TO EXAMINER
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU EXTENSION 1 GRANTED
Monday, October 28, 2024SOU EXTENSION 1 FILED